Chronic constipation and abdominal pain: Independent or closely interrelated symptoms?

被引:29
作者
Wong, May Y. W. [1 ,2 ,3 ,4 ]
Hebbard, Geoffrey [3 ,4 ]
Gibson, Peter R. [1 ,2 ]
Burgell, Rebecca E. [1 ,2 ]
机构
[1] Alfred Hlth, Dept Gastroenterol, 55 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Monash Univ, 55 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[4] Univ Melbourne, Melbourne, Vic, Australia
关键词
Abdominal pain; Chronic constipation; Irritable bowel syndrome; PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; CHLORIDE CHANNEL ACTIVATOR; BALANCED SOLUTION PMF-100; DOUBLE-BLIND; CLINICAL-TRIAL; ELDERLY-PATIENTS; MULTICENTER; PRUCALOPRIDE;
D O I
10.1111/jgh.14970
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Constipation is both a symptom and a disorder, seen in both functional constipation and irritable bowel syndrome with constipation predominance (IBS-C). Despite the Rome IV criteria distinguishing between these conditions, they share many therapeutic approaches. This review aims to explore the relationship between constipation and abdominal pain and assess the evidence surrounding whether laxation improves abdominal pain and whether such a response to laxation differs between IBS-C and functional constipation. In patients with functional constipation, increasing frequency of bowel motions by laxatives regardless of mechanism of action is associated with reductions in the severity of abdominal pain, supporting the role of constipation as a contributor to abdominal discomfort. In patients with IBS-C, evidence from systematic reviews indicates that abdominal pain is driven by factors additional to constipation alone and that visceral analgesic modulation is also needed to optimize pain. Changing definitions of IBS-C and heterogeneity in clinical trial design including endpoints have raised uncertainty about the comparative ability of older laxatives without known neuromodulatory effects to improve chronic abdominal pain compared with new secretagogues and prokinetics for the management of IBS-C. While it is known that abdominal pain is associated with constipation and laxation contributes to relief of that pain, it remains unproven whether proposed visceral analgesic properties of new laxatives provide greater pain relief than laxation alone. However, it is likely that the response to laxation in IBS-C is only part of the puzzle.
引用
收藏
页码:1294 / 1301
页数:8
相关论文
共 77 条
[1]  
Ashraf W, 1995, ALIMENT PHARM THER, V9, P639, DOI 10.1111/j.1365-2036.1995.tb00433.x
[2]   A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome [J].
Awad, R. A. ;
Camacho, S. .
COLORECTAL DISEASE, 2010, 12 (11) :1131-1138
[3]  
Baldonedo Y C, 1991, G E N, V45, P294
[4]   Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation [J].
Barish, Charles F. ;
Drossman, Douglas ;
Johanson, John F. ;
Ueno, Ryuji .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) :1090-1097
[5]   THE LAXATIVE EFFECTS OF LACTULOSE IN NORMAL AND CONSTIPATED SUBJECTS [J].
BASS, P ;
DENNIS, S .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1981, 3 :23-28
[6]  
Bassotti G, 2011, REV ESP ENFERM DIG, V103, P25, DOI 10.4321/s1130-01082011000100005
[7]   Different perception of chronic constipation between patients and gastroenterologists [J].
Bellini, M. ;
Gambaccini, D. ;
Salvadori, S. ;
Bocchini, R. ;
Pucciani, F. ;
Bove, A. ;
Alduini, P. ;
Battaglia, E. ;
Bassotti, G. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (08)
[8]   Anorectal manometry and imaging are necessary in patients with fecal incontinence [J].
Bharucha, Adil E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (12) :2679-2681
[9]   Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis [J].
Bielefeldt, Klaus ;
Levinthal, David J. ;
Nusrat, Salman .
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (01) :31-45
[10]   Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials [J].
Brenner, Darren M. ;
Fogel, Ronald ;
Dorn, Spencer D. ;
Krause, Richard ;
Eng, Paul ;
Kirshoff, Robert ;
Nguyen, Anhthu ;
Crozier, Robert A. ;
Magnus, Leslie ;
Griffin, Patrick H. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (05) :735-745